Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic

Mahsa Ghajarzadeh, Omid Mirmosayyeb, Mahdi Barzegar, Nasim Nehzat, Saeed Vaheb, Vahid Shaygannejad, Amir‐Hadi Maghzi